Charterhouse Capital Partners’ Acquisition Of Phastar

Paolo Bossi

Macfarlanes has advised Charterhouse Capital Partners on the tax aspects of its acquisition of Phastar. Phastar is a fast growing, specialist biometrics clinical research organisation (CRO)…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

…

This content is for Standard 1 Year members only.
Login Join Now